ConductScience.org, home

Paper31329461

Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.

Austin GL and 11 others. Mol Pharm, 2019. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease. Papers, record 31329461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31329461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.
PubMed
Journal
Mol Pharm
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.06
iCite
Revised in PubMed
2021-06-04
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Austin GLGrant Lhttps://orcid.org/0000-0002-9122-1022
2Simmons ZRZoe R
3Klier JEJack E
4Rondon AAlberto
5Hodges BLBrad L
6Shaffer RRobert
7Aziz NMNadine M
8McKnight TRTracy R
9Pauly JRJames R
10Armstrong DDDustin D
11Vander Kooi CWCraig W
12Gentry MSMatthew Shttps://orcid.org/0000-0001-5253-9049

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
Drug Delivery SystemsMajor topic
Immunoglobulin Fab FragmentsMajor topic
Lafora DiseaseMajor topic
Pancreatic alpha-AmylasesMajor topic
Animals
Artificial Gene Fusion
Disease Models, Animal
Drug Carriers
Enzyme-Linked Immunosorbent Assay
Glucans
HEK293 Cells
Humans
Mice
Mice, Knockout
Plasmids
Protein Tyrosine Phosphatases, Non-Receptor
Tissue Distribution
Treatment Outcome

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 NS097197NINDS NIH HHSUnited StatesP01NS097197PubMed and NIHNIH RePORTER
P30 CA177558NCI NIH HHSUnited StatesP30CA177558PubMed and NIHNIH RePORTER
R01 NS070899NINDS NIH HHSUnited StatesR01NS070899PubMed and NIHNIH RePORTER
TL1 TR001997NCATS NIH HHSUnited StatesTL1TR001997PubMedNIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127702709Lafora disease.Epileptic Disord2016https://conductscience.org/library/papers/27702709PubMed
217525162Intranuclear protein transduction through a nucleoside salvage pathway.J Biol Chem2007https://conductscience.org/library/papers/17525162PubMed
325449807Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging.J Control Release2015https://conductscience.org/library/papers/25449807PubMed
417952067Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.Nat Neurosci2007https://conductscience.org/library/papers/17952067PubMed
523026637Fusion protein linkers: property, design and functionality.Adv Drug Deliv Rev2013https://conductscience.org/library/papers/23026637PubMed
624452334Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease.Hum Mol Genet2014https://conductscience.org/library/papers/24452334PubMed
728154884Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.J Mol Med (Berl)2017https://conductscience.org/library/papers/28154884PubMed
823307925Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.Hum Mol Genet2013https://conductscience.org/library/papers/23307925PubMed
929483193Lafora disease offers a unique window into neuronal glycogen metabolism.J Biol Chem2018https://conductscience.org/library/papers/29483193PubMed
1029023798Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery.J Physiol2018https://conductscience.org/library/papers/29023798PubMed
1129475602The 3rd International Lafora Epilepsy Workshop: Evidence for a cure.Epilepsy Behav2018https://conductscience.org/library/papers/29475602PubMed
1222364389Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii.FEBS J2013https://conductscience.org/library/papers/22364389PubMed
1330265523Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.Bioconjug Chem2018https://conductscience.org/library/papers/30265523PubMed
1414237775LAFORA'S DISEASE. DISTINCT CLINICO-PATHOLOGIC FORM OF UNVERRICHT'S SYNDROME.Arch Neurol1965https://conductscience.org/library/papers/14237775PubMed
154104134Studies in myoclonus epilepsy. 3. The effects of amylolytic enzymes on the ultrastructure of Lafora bodies.J Histochem Cytochem1971https://conductscience.org/library/papers/4104134PubMed
1621552327PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease.PLoS Genet2011https://conductscience.org/library/papers/21552327PubMed
174164450Isolation and characterization of Lafora bodies in two cases of myoclonus epilepsy.J Neuropathol Exp Neurol1967https://conductscience.org/library/papers/4164450PubMed
1820036416Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins.J Allergy Clin Immunol2010https://conductscience.org/library/papers/20036416PubMed
194175641Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.Arch Neurol1968https://conductscience.org/library/papers/4175641PubMed
2029793829Best practices for the use of intracerebroventricular drug delivery devices.Mol Genet Metab2018https://conductscience.org/library/papers/29793829PubMed

See all 46 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
41898855SINEUP-Mediated Overexpression of Endogenous α-Amylase as a Therapeutic Approach in Lafora Disease.Genes (Basel)2026https://conductscience.org/library/papers/41898855PubMed
41825228Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation.Neurotherapeutics2026https://conductscience.org/library/papers/41825228PubMed
41465357Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in Epm2b-Deficient Mice.Int J Mol Sci2025https://conductscience.org/library/papers/41465357PubMed
41326286New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment.Neurotherapeutics2026https://conductscience.org/library/papers/41326286PubMed
40876194The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness.Epilepsy Behav2025https://conductscience.org/library/papers/40876194PubMed
40711973Recombinant human alpha-N-acetylglucosamine-6-sulfatase delivered to Sanfilippo D mice with repeated intracerebroventricular injections corrects CNS pathology.PLoS One2025https://conductscience.org/library/papers/40711973PubMed
39277505Neurological glycogen storage diseases and emerging therapeutics.Neurotherapeutics2024https://conductscience.org/library/papers/39277505PubMed
38137127Lafora Disease: A Case Report and Evolving Treatment Advancements.Brain Sci2023https://conductscience.org/library/papers/38137127PubMed
37700152Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.Neurotherapeutics2023https://conductscience.org/library/papers/37700152PubMed
37554056The multifaceted roles of the brain glycogen.J Neurochem2024https://conductscience.org/library/papers/37554056PubMed
36059248In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues.EMBO Mol Med2022https://conductscience.org/library/papers/36059248PubMed
35835895Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model.Mol Neurobiol2022https://conductscience.org/library/papers/35835895PubMed
35743315Trehalose Treatment in Zebrafish Model of Lafora Disease.Int J Mol Sci2022https://conductscience.org/library/papers/35743315PubMed
34755096An empirical pipeline for personalized diagnosis of Lafora disease mutations.iScience2021https://conductscience.org/library/papers/34755096PubMed
34301405Lafora disease: Current biology and therapeutic approaches.Rev Neurol (Paris)2022https://conductscience.org/library/papers/34301405PubMed
34043942Brain glycogen serves as a critical glucosamine cache required for protein glycosylation.Cell Metab2021https://conductscience.org/library/papers/34043942PubMed
33960213A novel gene therapy for neurodegenerative Lafora disease via EPM2A-loaded DLinDMA lipoplexes.Nanomedicine (Lond)2021https://conductscience.org/library/papers/33960213PubMed
33946009The 6th International Lafora Epilepsy Workshop: Advances in the search for a cure.Epilepsy Behav2021https://conductscience.org/library/papers/33946009PubMed
33602551251st ENMC international workshop: Polyglucosan storage myopathies 13-15 December 2019, Hoofddorp, the Netherlands.Neuromuscul Disord2021https://conductscience.org/library/papers/33602551PubMed
31932179The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic.Epilepsy Behav2020https://conductscience.org/library/papers/31932179PubMed

See all 21 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AMY2A279PubTator's text mininghttps://conductscience.org/library/genes/279NCBI Gene
CBLL2158506PubTator's text mininghttps://conductscience.org/library/genes/158506NCBI Gene
EPM2A7957PubTator's text mininghttps://conductscience.org/library/genes/7957NCBI Gene
NHLRC1378884PubTator's text mininghttps://conductscience.org/library/genes/378884NCBI Gene
SUCO51430PubTator's text mininghttps://conductscience.org/library/genes/51430NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31329461

GET https://conductscience.org/api/papers/v1/31329461/references?page=2